Dr. Jodi Spelay MD, FRCSC

Areas of Interest:

• Vascular and Endovascular Surgery

Current Appointments:

• Surgical Society Memberships:
  • 2012 - present - SVS (Society Vascular Surgery - American)
  • 2004 - present - Canadian Association of Wound Care
  • 2000 - present - Canadian Society for Vascular Surgery
  • 2000 - present - Canadian Association of General Surgeons
  • 1992 - present - Canadian Medical Association
  • 1992 - present - Saskatchewan Medical Association
  • 1998 - 2000 - MB Medical Association
• Associate Menberships:
  • 2008 - present - Society of Vascular Surgery American
  • 1996 - present - American College of Surgeons
• Committee Memberships:
  • 2006 - present - Steering Committee of Regional Wound Standardization Committee
  • 2006 - present - Skin and Wound Committee - Saskatoon Health Care District -Vascular Surgery Consultant
  • 2005 - present - Saskatchewan Medical Association -Awards Appointment Committee
  • 2003 - present - Diabetic Foot Management Initiative (develop guidelines, government pilot project)
  • 2002 - present - Chair of Saskatoon Medical Capital Equipment
  • 2001 - present - Assistant Director of Saskatoon Vascular Laboratory
  • 2000 - present - Canadian Society of Vascular Surgery
  • 2000 - present - St. Paul's General Surgery Department - Secretary
  • 2000 - present - Wound and Stoma Management Committee - advisory role in vascular disease
  • 1992 - present - Canadian Medical Association

Academic Background:

• 1993 - Rotating Internship, St. Paul's Hospital, Saskatoon, SK
• 1992 - MD, University of Saskatchewan
• 1988 - Pre-Medicine, University of Saskachewan

Awards:

• 2006 - Department of Surgery Annual Residents Research Day, 1st prize
• 2004 - Clinical Faculty Appreciation Award, University of Saskchewan
• 1999 - American College of Surgeons (MB Chapter)

Brief Description of Funded Research:

• 2016 - ongoing - Gecko Perfusion device - common peroneal nerve stimulation - hemodynamic effects of the augmentation of venous arterial and microvascular blood supply of the lower extremities.
• 2015 - ongoing - Principal Investigator, CLI study- Best Endovascular VS Best Surgical Therapy in Patients with Critical Limb lschemia.
• Characterization of sex steroid receptors in breast and endometrial tissue in perimenopausal women- the relationship to BRCA1, several steroid concentrators and chibbar, et al.
• Sub-investigator, Clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance. A Phase Ill multi-center, multi-national, randomized, parallel group, double-blind trial of Clopidogrel versus placebo in high-risk patients aged 45 years and older, at risk of atherothrombotic events, and who are receiving background therapy including low-dose ASA.
• 2002 - Principal Investigator, A Phase Ill multi-center randomized, double blind, placebo-controlled trial of the Ex-Vivo treatment with CGT003 of Peripheral Vein grafts in patients undergoing peripheral arterial bypass graft procedures.
• Innovation Proposal - Health Quality Council re: Diabetic Lower Extremity Clinic Development
• OR Allocation Working Group Division of General Surgery, Saskatoon District Health
• 2002 - Western Canada Wait List - Development Committee, vascular representative
• 2002 - Sub-investigator, Randomized double-blind multi-center compared to Phase Ill study of intravenous BMS 284756 followed by oral BMS 284756 versus intravenous Piperacillin/Tazobactam followed by oral Amoxicillin/Clavulante acid in the treatment of complicated intra-abdominal infections.
• 2002- Sub-investigator, Double-blind placebo controlled parallel group studying the effects of Endothelin BMS 20794A on patients with peripheral vascular disease and evidence based claudication (BMS protocol CV154-009).
• 2001 - Principal Investigator, -    Enhanced MRA in patients with suspected peripheral vascular disease (July, 31, 2001), EPIX multi-center Phase Ill study to determine the safety and efficacy of MS32.
• 2001 - Principal Investigator, WAVE -Warfarin and anti-platelet vascular evaluation, Phase Ill randomized study of Warfarin and anti-platelet therapy versus anti-platelet therapy alone in patients with peripheral vascular disease, multi-center
• 2001 - Sub-investigator, Controlled clinical trial, multi-center, Randomized perspective study comparing conventional therapy and the Art assist device in chronic critical limb ischemia - Phase 2.
• 2001 - Sub-investigator, A double-blind, placebo, controlled, parallel group study of the effects of CP-597,396 on peri-operative cardiac events in high risk subjects undergoing non-cardiac vascular surgery, Fall.
• 2000 - Principal Investigator, Parexel - Protocol No. 2000-042 recombinant Urokinase in the treatment of occluded central venous catheters - safety, efficacy trial.